Is this you? Create Your Porfile
Avatar

Wakita Takaji

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Wakita Takaji is active.

Explore More

Publication

Featured researches published by Wakita Takaji.

PLOS Pathogens | 2016

SR-B1 and LDLR have a redundant role in HCV entry.

Yamamoto Satomi; Fukuhara Takasuke; Ono Chikako; Uemura Kentaro; Kawachi Yukako; Shiokawa Mai; Mori Hiroyuki; Wada Masami; Shima Ryoichi; Okamoto Toru; Hiraga Nobuhiko; Suzuki Ryosuke; Chayama Kazuaki; Wakita Takaji; Matsuura Yoshiharu

PLOS Pathogens | 2016

SR-B1, LDLR and VLDLR participate in the binding step of HCV entry.

Yamamoto Satomi; Fukuhara Takasuke; Ono Chikako; Uemura Kentaro; Kawachi Yukako; Shiokawa Mai; Mori Hiroyuki; Wada Masami; Shima Ryoichi; Okamoto Toru; Hiraga Nobuhiko; Suzuki Ryosuke; Chayama Kazuaki; Wakita Takaji; Matsuura Yoshiharu

PLOS Pathogens | 2016

SR-B1 is dispensable for HCV entry into Huh7 cells.

Yamamoto Satomi; Fukuhara Takasuke; Ono Chikako; Uemura Kentaro; Kawachi Yukako; Shiokawa Mai; Mori Hiroyuki; Wada Masami; Shima Ryoichi; Okamoto Toru; Hiraga Nobuhiko; Suzuki Ryosuke; Chayama Kazuaki; Wakita Takaji; Matsuura Yoshiharu

PLOS Pathogens | 2016

VLDLR has a similar role with SR-B1 and LDLR in HCV entry.

Yamamoto Satomi; Fukuhara Takasuke; Ono Chikako; Uemura Kentaro; Kawachi Yukako; Shiokawa Mai; Mori Hiroyuki; Wada Masami; Shima Ryoichi; Okamoto Toru; Hiraga Nobuhiko; Suzuki Ryosuke; Chayama Kazuaki; Wakita Takaji; Matsuura Yoshiharu

PLOS Pathogens | 2016

Deficiencies of SR-B1 and LDLR impair HCV entry.

Yamamoto Satomi; Fukuhara Takasuke; Ono Chikako; Uemura Kentaro; Kawachi Yukako; Shiokawa Mai; Mori Hiroyuki; Wada Masami; Shima Ryoichi; Okamoto Toru; Hiraga Nobuhiko; Suzuki Ryosuke; Chayama Kazuaki; Wakita Takaji; Matsuura Yoshiharu

PLOS Pathogens | 2016

Density-dependent entry of LVPs via lipoprotein receptors.

Yamamoto Satomi; Fukuhara Takasuke; Ono Chikako; Uemura Kentaro; Kawachi Yukako; Shiokawa Mai; Mori Hiroyuki; Wada Masami; Shima Ryoichi; Okamoto Toru; Hiraga Nobuhiko; Suzuki Ryosuke; Chayama Kazuaki; Wakita Takaji; Matsuura Yoshiharu

PLOS Pathogens | 2016

Lipid binding and lipid uptake of lipoprotein receptors participate in HCV entry.

Yamamoto Satomi; Fukuhara Takasuke; Ono Chikako; Uemura Kentaro; Kawachi Yukako; Shiokawa Mai; Mori Hiroyuki; Wada Masami; Shima Ryoichi; Okamoto Toru; Hiraga Nobuhiko; Suzuki Ryosuke; Chayama Kazuaki; Wakita Takaji; Matsuura Yoshiharu

Biological & Pharmaceutical Bulletin | 2016

オクルディンをノックアウトしたヒト肝Huh7.5.1‐8由来細胞はC型肝炎ウイルス感染に対して完全に耐性である

Shirasago Yoshitaka; Shimizu Yoshimi; Tanida Isei; Suzuki Tetsuro; Suzuki Ryosuke; Sugiyama Kazuo; Wakita Takaji; Hanada Kentaro; Yagi Kiyohito; Kondoh Masuo; Fukasawa Masayoshi

PLOS ONE | 2015

HCV NS5A reduced MG132-induced apoptosis.

Jiang Xia; Kanda Tatsuo; Wu Shuang; Nakamoto Shingo; Nakamura Masato; Sasaki Reina; Haga Yuki; Wakita Takaji; Shirasawa Hiroshi; Yokosuka Osamu

PLOS ONE | 2014

Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) protects hepatocytes from thapsigargin-induced apoptosis.

Jiang Xia; Kanda Tatsuo; Wu Shuang; Nakamoto Shingo; Wakita Takaji; Shirasawa Hiroshi; Yokosuka Osamu

Explore More

Collaboration

Dive into the Wakita Takaji's collaboration.

Top Co-Authors
Avatar

Shirasawa Hiroshi

Chiba University

View shared research outputs
Top Co-Authors
Avatar

Saito Kengo

Chiba University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge